Search results for: Precision Medicine
Filter search results
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
1 May 2019
Increasingly, scientific advances are delivering new medicines that deliver improved survival and quality of life across multiple treatment indications. Indication-Based Pricing (IBP) has been proposed as a way to better…
Diabetes: a Model for Health Care Management
10 January 1989
…deal has happened. For one thing diabetes mellitus has been accepted as an international problem by the World Health Organisation. Professor Hoet, father of the present Professor of Medicine at…
Keep on Taking the Tablets? A Review of the Problem of Patient Non-Compliance
1 October 1983
There has always been a problem in making sure that patients take the medicines which doctors prescribe for them in accordance with their instructions. The problem varies from the patients…
Around the world in HTAs: China – From fragmentation to function
2 September 2025
…List (NRDL), which determines which medicines are eligible for coverage under the two major public insurance schemes. Prior to 2017, the NRDL was updated infrequently and through a highly opaque…
New OHE Report: Time Trends in NICE HTA Decisions
25 January 2012
…innovative care and ensure more rapid access to medicines identified as being of value to the NHS. Since NICE’s debut in April 1999, several analyses have examined the uptake of…
Industrial Policy and the Pharmaceutical Industry
1 January 1995
…both ‘health and safety’ and ‘economic’ regulation. The former primarily governs the licensing procedures before a new medicine can be put on the market. The latter has two key elements…
New Business Models for Antibiotics
22 April 2014, 11:00pm
…Medicine & Ethics and is faculty co-advisor to the American Journal of Law & Medicine. Before teaching, Professor Outterson was a partner at two major US law firms. The slide presentation for this…
OHE Lunchtime Seminar: Early Experience with HTA of Gene Therapies in the US: Pricing and Paying for Cures
21 October 2018, 11:00pm
…price and coverage negotiation. Dr Pearson is a Lecturer in the Department of Population Medicine at Harvard Medical School and also serves as Visiting Scientist in the Department of Bioethics…
Health Care in China
1 September 1988
…of this appears to have been achieved by a successful concentration on public health and preventive medicine, which may perhaps only be possible within a highly disciplined and closely knit…